Literature DB >> 31080332

Pharmaceutical Approval Update.

Michele B Kaufman.   

Abstract

Cablivi (caplacizumab-yhdp) for acquired thrombotic thrombocytopenic purpura; Egaten (triclabendazole) for fascioliasis; and Spravato (esketamine) for treatment-resistant depression.

Entities:  

Year:  2019        PMID： 31080332      PMCID： PMC6487979     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  5 in total

Review 1.  Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.

Authors:  Satoshi Deyama; Ronald S Duman
Journal:  Pharmacol Biochem Behav       Date:  2019-12-09       Impact factor: 3.533

Review 2.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

3.  Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology.

Authors:  Mikaela K Dimick; Danielle Omrin; Bradley J MacIntosh; Rachel H B Mitchell; Daniel Riegert; Anthony Levitt; Ayal Schaffer; Susan Belo; John Iazzetta; Garfield Detzler; Mabel Choi; Stephen Choi; Beverley A Orser; Benjamin I Goldstein
Journal:  Contemp Clin Trials Commun       Date:  2020-06-23

4.  Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.

Authors:  Mitchell J Bartlett; Andrew J Flores; Tony Ye; Saskia I Smidt; Hannah K Dollish; Jennifer A Stancati; Drew C Farrell; Kate L Parent; Kristian P Doyle; David G Besselsen; Michael L Heien; Stephen L Cowen; Kathy Steece-Collier; Scott J Sherman; Torsten Falk
Journal:  Exp Neurol       Date:  2020-07-25       Impact factor: 5.330

5.  The brain targeted delivery of programmed cell death 4 specific siRNA protects mice from CRS-induced depressive behavior.

Authors:  Yufeng Jia; Xiao Zhuang; Yi Zhang; Ming Zhao; Nuo Chen; Wen Li; Faliang Zhu; Chun Guo; Yan Li; Qun Wang; Yuan Li; Lining Zhang
Journal:  Cell Death Dis       Date:  2021-11-12       Impact factor: 8.469
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.